baber/WOPTO huggingface dataset:
Patent NZ-599184-A (NZ)
Title: Methods for producing milk-derived nutritional compositions for the treatment of osteoporosis
Inventor: VEMBU RAJAN V
IPC: A23K1/18
Filed: 2010-09-24
Abstract: Patent No. 599184 Disclosed is a method of making a nutritional composite material comprising the steps of a) providing whey-derived milk minerals in solid form; b) providing milk-derived basic protein in solution; c) exposing the milk-derived protein solution of step b. to an ion exchange step to enhance the weight percent milk-derived basic proteins in the solution; d) removing sodium-based minerals and sodium salts from the milk-derived basic protein solution; e) purifying the milk-derived solid minerals by mixing the minerals with a solvent and heating the solution; f) combining the purified milk-derived solid mineral solution of the previous step with the enhanced milk-derived basic protein solution of step d); g) removing the solvent of the previous step to produce the nutritional composite material.
Patent NZ-600381-A (NZ)
Title: Raw water hardness determination in a water treatment system via the conductivity of soft or blended water
Inventor: SOCKNICK RALF
IPC: G01N33/18
Filed: 2010-12-15
Abstract: Disclosed is a method for operating a water treatment system having a softening device. The softening device comprises an ion-exchange resin, a conductivity sensor, an electronic control device and an automatically adjustable blending device for mixing a blended water stream (V(t)blend) from a first, softened part-stream (V(t)part1soft) and a second, raw-water-carrying part-stream (V(t)part2raw). The conductivity of the softened water or the conductivity of the blended water is determined experimentally. The conductivity of the raw water and/or the total hardness of the raw water is derived from the experimentally determined conductivity of the softened water or of the blended water. In the derivation of the conductivity of the raw water and/or the total hardness of the raw water from the experimentally determined conductivity of the softened water or of the blended water, a correction of the different conductivities of one calcium or magnesium ion and two sodium ions is carried out by means of one or more functions. The derived conductivity of the raw water and/or total hardness of the raw water is used to adjust the hardness of the blended water stream (V(t)blend) by correspondingly adjusting the mixing ratio of the two part-streams (V(t)part1soft) and (V(t)part2raw) to a given desired value.
Patent NZ-601696-A (NZ)
Title: Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
Inventor: TRIPP MATTHEW L
IPC: A61K31/12
Filed: 2008-12-10
Abstract: ABSTRACT - 601696 The disclosure relates to the use of a composition for manufacturing a medicament for modulating a protein kinase in a mammal in need thereof, said use comprising formulating the medicament for administration to the mammal, wherein the medicament comprises a therapeutically effective amount of a substituted 1,3-cyclopentadione compound, wherein the protein kinase modulated is selected from the group consisting of ATK, FGFR3, c-Jun NH2-terminal kinase-3 (JNK3), Phosphoinositide-dependent kinase (PDK) and phosphatidylinositol-3-kinase (PI3K), and wherein the substituted 1,3-cyclopentadione compound is hexahydroisoalpha acids, and wherein composition may further comprise a pharmaceutically acceptable excipient selected from the group consisting of coatings, isotonic and absorption delaying agents, binders, adhesives, lubricants, disintergrants, coloring agents, flavoring agents, sweetening agents, absorbants, detergents, and emulsifying agents, as well as further members selected from the group consisting of antioxidants, vitamins, minerals, proteins, fats, and carbohydrates.
Patent NZ-602327-A (NZ)
Title: Training device for rugby players
Inventor: COUVET SERGE
IPC: A63B24/00
Filed: 2011-02-09
Abstract: Disclosed is a scrum machine training device (30) for rugby players. The scrum machine device (30) is comprised of a Stewart or hexapod platform (1) onto which a training yoke is mounted, an electronic device (32) for closed loop control of the platform (1) and a digital device (33) for controlling the training device (30). The training yoke is comprised of yoke heads, wherein each yoke head is connected to the simulation platform (1) via a force sensor. The force sensors supply measurements used for the closed-loop control of the simulation platform (1). The measurements are transmitted to a computer control device (33) for archiving and presentation of the measurements to a coach of the players.
Patent NZ-603502-A (NZ)
Title: Defoamers for hydratable cementitious compositions
Inventor: KUO LAWRENCE L
IPC: C04B24/12
Filed: 2011-05-17
Abstract: The disclosure relates to additive compositions, cementitious compositions, and methods for controlling air in cementitious compositions, wherein a polyalkoxylated polyalkylene polyamine defoamer is deployed in combination with one or more air-entraining agents, such as higher alkanolamines, water-reducing agents including oxyalkylene-containing superplasticizers, or other air entraining agents. Particularly disclosed is a composition for controlling air in hydratable cementitious compositions, comprising: (A) at least one agent operative to entrain air in a hydratable cementitious composition, said at least one agent comprising a higher trialkanolamine, a lignosulfonate, a naphthalene sulfonate, a melamine sulfonate, an oxyalkylene-containing superplastizicer, an oxyalkylene-containing shrinkage reducing agent, or mixture thereof; (B) a polyalkoxylated polyalkylene polyamine defoamer formed by alkoxylating a polyalkylene polyamine with ethylene oxide, propylene oxide, or mixture thereof, wherein the amount of ethylene oxide groups is in the range of 0%-40% based on total weight of polyethers, and the amount of polypropylene oxide groups is in the range of 60%-100% based on total weight of polyethers, the molar ratio of propylene oxide to ethylene oxide being greater than 1, said polyalkoxylated polyalkylene polyamine defoamer having a structure represented by formula (1), wherein the variables are as defined in the specification; and (C) the ratio of component A to component B is in the range of 5 to 100 by dry weight.
Patent NZ-607494-A (NZ)
Title: Pharmaceutical composition and administrations thereof
Inventor: DOKOU ELENI
IPC: A61K31/47
Filed: 2011-08-26
Abstract: Provided are pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis( 1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (ivacaftor). In one embodiment a pharmaceutical composition comprises a solid dispersion of amorphous or substantially amorphous ivacaftor in an amount of about 15 to about 47 percent by weight of the composition; sucralose in an amount of about 2 percent by weight of the composition; croscarmellose sodium in an amount from about 3 to about 6 percent of by weight of the composition; sodium lauryl sulfate (SLS) in an amount of about 0 to about 0.5 percent by weight of the composition; colloidal silicon dioxide in an amount of about 1 percent by weight of the composition; magnesium stearate in an amount of about 1.5 percent by weight of the composition; and mannitol in an amount of about 42 to about 77.5 percent of by weight of the composition. The pharmaceutical compositions are useful in the treatment of CFTR mediated diseases, such as cystic fibrosis.
Patent NZ-609490-A (NZ)
Title: Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
Inventor: WANG BING
IPC: C07D487/14
Filed: 2011-10-20
Abstract: The disclosure relates to (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt (abstract figure), specifically in a crystalline form. The crystalline form has a solid state 13C NMR spectrum with peaks at 143.2, 136.0, 131.8, 123.9, 112.2, 105.2 and 100.3 ppm ± 0.2 ppm; a differential scanning calorimetry thermogram having an endotherm with a maximum at between about 320°C and about 335 °C; a thermogravimetric analysis thermogram indicative of an unsolvated material; a dynamic vapour sorption isotherm plot which does not exhibit a significant weight change from 0 to 95% relative humidity; an X-ray powder diffraction pattern comprising characteristic peaks expressed in d-values (Å) of about 11.9, 5.9, 4.9, 4.4, 4.3, 3.9, and 3.7; and an X-ray powder diffraction pattern comprising peaks at 2 θ angle degrees ± 0.2 2θ angle degrees of 7.4, 15.1, 18.1, 20.1, 20.4, 22.6 and 24.0. The disclosure also relates to methods of synthesising and crystallising the compound and methods of treating as disease or condition, including cancer, using the compound.
Patent NZ-611268-A (NZ)
Title: Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Inventor: AHMED SALAH U
IPC: A61F6/14
Filed: 2009-02-03
Abstract: Disclosed herein is the use of (a) a therapeutically effective amount of progesterone; (b) a polysiloxane eleastomer; and (c) a pharmaceutically acceptable hydrocarbon or glycerol ester of a fatty acid for the manufacture of a medicament for the treatment of an infertile woman with progesterone deficiency, wherein said medicament is a monolithic intravaginal ring comprising said therapeutically effective amount of progesterone, said polysiloxane elastomer and said pharmaceutically acceptable hydrocarbon or glycerol ester of a fatty acid, wherein the intravaginal ring is adapted for administration of about 10 mg to about 20 mg progesterone per day at a steady state for up to 18 days after administration to the subject; and wherein the polysiloxane elastomer is present in a concentration of about 55% to about 90% by total weight of the ring.
Patent NZ-614050-A (NZ)
Title: Cam lever actuated cable sealing device
Inventor: VASTMANS KRISTOF
IPC: H02G15/117
Filed: 2012-05-08
Abstract: The present disclosure relates to a cable sealing device (30) for providing a seal around a communications cable (88, 90). The cable sealing device (30) includes a cable seal arrangement (38) positioned between first and second compression plates (92F, 92R). The cable sealing device (30) also includes an actuator (36) for compressing the first and second compression plates (92F, 92R) together to deform the cable sealing arrangement (38) such that the cable sealing arrangement (38) is adapted to form a seal about a cable (88, 90) routed through the cable sealing device (30). The actuator includes a cam lever (94) pivotally movable between an actuated position (P2) and a non-actuated position (P1). The actuator also includes a spring (98) for transferring load between the cam lever (94) and the first and second compression plates (92F, 92R). The spring (98) is pre-loaded when the cam lever (94) is in the non-actuated position (P1) (Figure 13) with a pre-load equal to at least about 50 percent of a total load applied through the spring (98) when the cam lever (94) is in the actuated position (P2).
Patent NZ-617196-A (NZ)
Title: Activin-actrii antagonists and uses for increasing red blood cell levels
Inventor: SHERMAN MATTHEW L
IPC: C12N15/62
Filed: 2007-12-18
Abstract: Discloses the use of an Activin-ActRII antagonist peptide which is at least 80% identical to SEQ ID NO: 2, 3, 7, 12, 16, 17, 20 or 21 in the manufacture of a medicament for treating myelodysplastic syndrome, sickle-cell disease or thalassemia.
Patent NZ-631431-A (NZ)
Title: A sterilisation container and method of sterilisation
Inventor: ALAN REG DOWMAN
IPC: B65B55/14
Filed: 2014-09-12
Abstract: Disclosed is a rigid or semi-rigid container for use with a steriliser that isolates the contents from the outside environment once sterilised. The container (1) has a base (2) and side walls (3-6) defining a cavity for containing an item during steam sterilisation and isolating it from its surroundings after sterilisation. A rim (7) extends outwardly from the walls; and a sealable conduit configured and arranged so that, in use, steam sterilant may be introduced into the container and steam sterilant and condensate may be removed from the container via the conduit. The conduit is provided at, in or near the base to facilitate draining of the container. The conduit is elongate in cross section in a plane generally parallel to the base. The conduit includes two opposing side walls that may be sealed together to seal the conduit. A method where a lid or seal is applied over the cavity after the contents are placed and steam steriliser are also disclosed.
Patent NZ-701515-A (NZ)
Title: Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
Inventor: DRESSMAN MARLENE MICHELLE
IPC: C07C233/47
Filed: 2013-05-17
Abstract: Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide and pharmaceutical compositions containing such metabolites are described, as well as their use in the manufacture of a medicament for the treatment of a circadian rhythm disorder, a disorder with a circadian component, a sleep disorder, jet lag, shift worker sleep, general anxiety disorder, major depressive disorder, seasonal affective disorder, attention deficit/hyperactivity disorder, Alzheimers Disease, Angelman Syndrome, bipolar disorder, schizophrenia, autism, epilepsy, migraine, night time hypertension, obesity, type 2 diabetes, or testosterone insufficiency.
Patent NZ-709990-A (NZ)
Title: Liquid oat base
Inventor: TRIANTAFYLLOU ANGELIKI
IPC: C12N9/24
Filed: 2014-01-28
Abstract: A process for preparing a liquid oat base or drink of improved soluble oat protein content from an oats material, in particular an oats material that has not been heat treated in a humid state, comprises solubilizing oat protein in an aqueous solvent by means of protein-deamidase. In one aspect, the invention provides a process for preparing a liquid oat base or drink of improved soluble oat protein content from an oats material comprising starch and oat protein, by suspending the oats material in an aqueous medium degrading starch of the oats material with one or more amylases and solubilizing oat protein by means of protein-deamidase without use of protease. Also disclosed are corresponding liquid oat bases and uses thereof.
Patent NZ-715834-A (NZ)
Title: Regulation of glucose metabolism using anti-cgrp antibodies
Inventor: SMITH JEFFREY T L
IPC: C07K16/26
Filed: 2014-07-03
Abstract: The present disclosure provides methods for the prevention or treatment of metabolic disorders. In exemplary embodiments, methods of administering an anti-CGRP antibody are provided, optionally in combination with a second agent, wherein peripheral and/or hepatic glucose utilization is increased, thereby preventing or treating diseases and disorders associated with insulin resistance, such as type II diabetes, obesity and/or preventing the loss of functional pancreatic beta cells. Compositions comprising an anti-CGRP antibody are also provided, optionally in combination with a second agent, which are suitable for administration to increase peripheral and/or hepatic glucose utilization and thereby prevent or treat diseases and disorders associated with insulin resistance.
Patent NZ-724961-A (NZ)
Title: Device for attaching ballistic protection elements
Inventor: FRANZ MANUEL
IPC: F41H5/013
Filed: 2015-04-08
Abstract: The invention relates to a device (1) comprising at least one welding cam (2-2”) for attaching ballistic protection elements (10) and additional add-on parts (11) to an object (5). In order to be able to attach a ballistic protection element (10) and an add-on part (11) to the same welding cam (2-2”) with different torques, a welding cam (2-2”) having a threaded bore (3) and an external thread (4) is proposed. In this case, the ballistic protection element (10) is screwed on with a first predefinable torque by means of a clamping nut (7; 7’) which can be screwed onto the external thread (4) of the welding cam (2-2”). For this purpose, the clamping nut (7; 7’) has a through-bore with an internal thread (8). Through this through-bore, the corresponding add-on part (11) can be connected to the threaded bore (3) of the welding cam (2-2”). Since the add-on part (11) bears against the clamping nut (7; 7’) and not against the ballistic protection element (10), the add-on part (11) can be attached to the welding cam (2-2”) with a second torque conforming to standards, without damaging the ballistic protection element (10).
Patent NZ-727980-A (NZ)
Title: Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
Inventor: OSTERLOH IAN
IPC: A61P3/06
Filed: 2011-11-28
Abstract: Disclosed is the use of ethyl eicosapentaenoate in the preparation of a medicament for treating hypertriglyceridemia in a subject identified as having a fasting baseline triglyceride level of about 200 mg/dl to about 500 mg/dl and as being allergic to fish or seafood, wherein said medicament composition contains substantially no docosahexaenoic acid (DHA) or derivative thereof, and less than about 1%, by weight, of proteins, if any, and wherein the medicament does not cause skin rash or wherein the subject experiences reduced incidence of skin rash compared to placebo or to an equivalent milligram dose of a commercially available prescription omega-3 fatty acid composition.
Patent NZ-731823-A (NZ)
Title: Portable physiology monitor
Inventor: MARSH LEON
IPC: A61B5/00
Filed: 2015-11-25
Abstract: A wearable device for measuring tympanic temperature, the device comprising an ear insert (100) comprising a retaining portion (220) formed to extend along and substantially fill an ear canal; a thermopile module (200) comprising a housing supporting an infrared thermopile (101) arranged at an innermost end of the retaining portion and arranged for measuring a tympanic temperature; a wired electrical connection extending through the ear insert for outputting a signal from the infrared thermopile; and an audio conduction channel, provided by an audio passageway (230) defined at least partially within the ear insert and configured as a waveguide to relay sound from an audio driver or an ambient environment to the innermost end of the ear insert, wherein an output of the audio passageway is at an innermost end of the ear insert to the rear of the forward end of the thermopile module and lateral to the thermopile module. Providing an infrared thermopile at the innermost end of the ear insert, close to the tympanic membrane, ensures measured temperatures can be reliably used to provide an indication of the core body temperature.
Patent NZ-734897-A (NZ)
Title: An apparatus and method for inspecting a pipeline
Inventor: NORLI PETTER
IPC: G01N29/34
Filed: 2016-02-24
Abstract: Testing of pipelines in the oil and gas industry, can be done using inspection pigs which travel inside the pipelines measuring the condition of the pipe wall. Methods for measuring the condition of pipeline walls include magnetic flux leakage and ultrasonic testing. Magnetic flux leakage is mainly effective for detecting metal loss and ultrasonic testing is used for detecting corrosion and cracks in pipeline walls. There is a need for a more efficient method. The present invention provides an apparatus for inspecting a pipeline, which includes a cylindrical body (15) adapted to be transported inside the pipeline and an array of acoustical transducers (Tx, y) installed in the surface of the cylindrical body (15). The acoustical transducers are organised in columns and rows in a belt around the cylindrical body (15). A controller (16, 18,19) initiates transmission of an acoustical signal from a first transducer and reception of said acoustical signal from other transducers in said array surrounding the first transducer, the controller also determines the distance and direction to a flaw in the wall of the pipeline from the received acoustical signals.
Patent NZ-739675-A (NZ)
Title: A drug delivery device
Inventor: RATHBONE MICHAEL
IPC: A61D7/00
Filed: 2016-07-11
Abstract: There are described delivery devices for insertion into a body cavity of a target non-human mammal to achieve delivery of an active agent into the non-human animal. The delivery device comprising a resilient frame adapted to receive one or more moulded impregnated masses formed from a polymer having a sheet-like form, having a thickness of about 0.1 to about 0.95 mm. The frame, together with the impregnated mass, are insertable, retainable and withdrawable from the intended body cavity. The impregnated mass or masses are attached to the frame to present substantially all of each face of the masses to exposure to a fluid of the body cavity when retained therein, and the ratio of the surface area of the one or more impregnated mass to the mass of the one or more impregnated mass is from 12:1 to 60:1 cm2.g-1. The claimed features reduce the amount of residual active agent left on the device after use and provide cost savings.
Patent NZ-741784-A (NZ)
Title: Oil compositions and methods of making
Inventor: STEFANSKI MICHAEL LENN
IPC: A23D9/02
Filed: 2016-10-05
Abstract: The present invention is directed to oil compositions that are enriched in polyunsaturated fatty acids; compositions containing the enriched oil compositions; and methods of making and using the enriched oil compositions. The oil is preferably a microbial or marine oil. More specifically the present invention is directed to a process for separation and concentration of an oil comprising esters of polyunsaturated fatty acids, the process comprising subjecting the oil to at least one distillation step, wherein a first distillation step comprises feeding the oil to at least one apparatus and subjecting the oil to conditions to remove low-boiling compounds in a distillate, and wherein a second distillation step comprises subjecting the oil to conditions to separate at least a portion of one long-chain polyunsaturated fatty acid (LC-PUFA) which is eicosapenaenoic acid (EPA) from at least a portion of a second LC-PUFA which is docosahexaenoic acid (DHA), wherein said at least one apparatus comprises a fractionating column that is attached to a wiped-film evaporator.
Patent NZ-758343-A (NZ)
Title: Flexible forehead support
Inventor: FLOWER (NEE DOHERTY) RENEE FRANCES
IPC: A61M16/06
Filed: 2008-06-19
Abstract: A respiratory mask includes a mask frame and cushion attached to the frame to seal around a patient’s face and forehead support provided to the mask frame (not shown). An elbow 50 is provided and has a transition portion that tapers from and between a larger internal diameter of a first portion 52 that connects to the frame, to a smaller internal diameter second portion 54 that connects to an air delivery tube. The transition portion has gas washout vents having axes that are not parallel to axes of the first or second portions.